Biotechnology News and Research

RSS

New study finds evidence to support meperidine-associated seizure risk

Meperidine, an opioid analgesic commonly used to control shivering in accidental or therapeutic hypothermia, has been linked to increased seizure risk, but a new study finds little published evidence to support this risk.

24 Nov 2015

LSP, Bristol-Myers Squibb announce immuno-oncology collaboration

LSP (Life Sciences Partners), the specialist healthcare investment firm, has announced today a strategic collaboration with Bristol-Myers Squibb Company in which the companies will work closely together in identifying European breakthrough technologies and products in immuno-oncology and other areas of unmet medical need.

24 Nov 2015

Microgravity inhibits regenerative and differentiation potential of embryonic stem cells

A study performed on the NASA Space Shuttle Discovery showed that exposure of mouse embryonic stem cells (mESCs) to microgravity inhibited their ability to differentiate and generate most cell lineages, needed for the development of bone, muscle, the immune system, and other organs and tissues.

24 Nov 2015

Special issue of Nanomedicine explores medical application of nanotechnology

Nanomedicine, a leading MEDLINE-indexed journal, has published a special focus issue highlighting the interdisciplinary nature of this emerging field, which explores the medical application of nanotechnology to monitor, repair, and control human biological systems at the molecular level.

23 Nov 2015

Mason researchers patent new breast cancer treatment

George Mason University researchers have patented a new breast cancer treatment that uses a common malaria drug to stop cancer in its beginning stages.

21 Nov 2015

Researchers devise system to accelerate the process of making life-saving vaccines

Researchers at Brigham Young University have devised a system to speed up the process of making life-saving vaccines for new viruses.

20 Nov 2015

Hapten Sciences plans to initiate Phase 1 clinical trial for new poison ivy vaccine

Hapten Sciences, Inc., a privately held biotechnology company, announced today that it has filed an Investigational New Drug (IND) application and is now planning to initiate dosing of healthy volunteers in a first-in-human Phase 1 clinical trial of its lead product candidate, PDC-APB, a novel, first-in-class, compound in development for a new indication to prevent contact dermatitis due to exposure to poison ivy, oak, and sumac.

19 Nov 2015

Researchers find mechanism to repair communication between neurons

A team of researchers led by professor Patrik Verstreken (VIB/KU Leuven) has exposed the fine details of a mechanism that provides more insight in the communication between neurons. The research has clarified how damaged synapses - the connection points between neurons - are repaired to keep communication between neurons at an optimal level.

19 Nov 2015

ProMetic, ProThera form strategic partnership to develop and commercialize Inter-alpha Inhibitor Proteins

ProMetic Life Sciences Inc. announced today that it has entered into a strategic partnership with ProThera Biologics Inc. for the development and commercialization of human plasma-derived Inter-alpha Inhibitor Proteins.

19 Nov 2015

New study identifies patient-reported barriers to quality end-of-life care among ethnic minorities

A new study identifies six main patient-reported barriers to receiving quality end-of-life (EOL) care among ethnic minority populations. The biggest barrier is lack of sufficient financial resources and insurance, according to the article published in Journal of Palliative Medicine, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.

19 Nov 2015

New article examines women's perceptions of relationship in Fifty Shades of Grey

Examining women's perceptions of the relationship between Christian and Anastasia in the popular movie Fifty Shades of Grey is a safe and valuable way to discuss healthy and unhealthy relationship dynamics, including the warning signs of intimate partner violence. Young women expressed mixed views, describing parts of the movie relationship as exciting and romantic and other aspects as controlling, manipulative, and emotionally abusive in a new study published in Journal of Women's Health, a peer-reviewed publication from Mary Ann Liebert, Inc., publishers.

19 Nov 2015

China Pharma's revenue decreases 19.5% to $4.8 million in Q3 2015

China Pharma Holdings, Inc., an NYSE MKT listed corporation with its fully-integrated specialty pharmaceuticals subsidiary based in China, today announced the financial results for the quarter ended September 30, 2015.

17 Nov 2015

New antenna-like device makes breast cancer surgery easier for surgeons

Breast cancer surgeons routinely face a dilemma: how to find tumors they cannot feel. Before going into the operating room they must use some method to locate them. Currently, the method they use requires a radiologist to insert a device into the woman's breast.

12 Nov 2015

Boston Children's Hospital selects Vijay G. Sankaran to receive Rising Star Award

Saluting his spectacular track record to date of innovative research on red blood cell disorders and his future promise as a physician/scientist, Boston Children's Hospital has selected Vijay G. Sankaran, MD, PhD, of Dana-Farber/Boston Children's Cancer and Blood Disorders Center to receive the Rising Star Award at the hospital's third annual Global Pediatric Innovation Summit, Taking on Tomorrow (#PedInno15).

11 Nov 2015

PAREXEL expands market access and clinical evidence services

PAREXEL International Corporation, a leading global biopharmaceutical services provider, today announced expanded evidence-based services for biopharmaceutical products.

10 Nov 2015

Astellas enters into definitive agreement to acquire Ocata

Astellas Pharma Inc. and Ocata Therapeutics, Inc., a biotechnology company focused on the research and development of new therapies in the field of regenerative medicine, primarily cell therapy addressing unmet medical needs in ophthalmology patients, announced today that they have entered into a definitive agreement.

10 Nov 2015

First comprehensive genomic and biologic study of top skin disease-causing microbes

An international team of scientists, led by researchers from A*STAR's Genome Institute of Singapore (GIS), Institute of Medical Biology (IMB), and Bioinformatics Institute (BII), and P&G, have completed the first comprehensive genomic and biologic study of all species of Malassezia, one of the top skin disease-causing microbes.

9 Nov 2015

RXi Pharmaceuticals begins Phase 1/2 clinical trial in ophthalmology

RXi Pharmaceuticals Corporation a biotechnology company focused on discovering and developing innovative therapies primarily in the areas of dermatology and ophthalmology today announced the initiation of a Phase 1/2 clinical trial in ophthalmology. The clinical study RXI-109-1501 will evaluate the safety and clinical activity of RXI-109 to prevent the progression of retinal scarring, a harmful component of numerous retinal diseases.

5 Nov 2015

University of Leicester awarded BBSRC grant to explore three key areas that impact human health

The University of Leicester has been awarded over £1.5 million in order to advance knowledge and understanding in three key areas that impact on health.

5 Nov 2015

Janssen doses first patient in daratumumab clinical trial using Halozyme's ENHANZE technology

Halozyme Therapeutics, Inc. today announced that Janssen Biotech, Inc. has dosed the first patient in a clinical trial evaluating subcutaneous (SC) delivery of daratumumab with Halozyme's proprietary ENHANZE technology in multiple myeloma.

5 Nov 2015

Biotechnology News and Research

New study finds evidence to support meperidine-associated seizure risk

LSP, Bristol-Myers Squibb announce immuno-oncology collaboration

Microgravity inhibits regenerative and differentiation potential of embryonic stem cells

Special issue of Nanomedicine explores medical application of nanotechnology

Mason researchers patent new breast cancer treatment

Researchers devise system to accelerate the process of making life-saving vaccines

Hapten Sciences plans to initiate Phase 1 clinical trial for new poison ivy vaccine

Researchers find mechanism to repair communication between neurons

ProMetic, ProThera form strategic partnership to develop and commercialize Inter-alpha Inhibitor Proteins

New study identifies patient-reported barriers to quality end-of-life care among ethnic minorities

New article examines women's perceptions of relationship in Fifty Shades of Grey

China Pharma's revenue decreases 19.5% to $4.8 million in Q3 2015

New antenna-like device makes breast cancer surgery easier for surgeons

Boston Children's Hospital selects Vijay G. Sankaran to receive Rising Star Award

PAREXEL expands market access and clinical evidence services

Astellas enters into definitive agreement to acquire Ocata

First comprehensive genomic and biologic study of top skin disease-causing microbes

RXi Pharmaceuticals begins Phase 1/2 clinical trial in ophthalmology

University of Leicester awarded BBSRC grant to explore three key areas that impact human health

Janssen doses first patient in daratumumab clinical trial using Halozyme's ENHANZE technology

Industry Focus eBook - Biotechnology (4th edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News